METHOD OF PREPARING MIRABILITUM PRAEPARATUM BY PURE STRAIN FERMENTATION AND ITS APPLICATIONS

Abstract

The present invention involves a method of preparing Mirabilitum Praeparatum by pure strain fermentation and its application in treating infectious and inflammatory diseases, as well as health products and cosmetics. The method involves blending the ripe fruit (watermelon) of Citrullus lanatus (Thumb.) Matsumu.et Nakai with Mirabilite (Na.sub.2SO.sub.4.10H.sub.2O) according to a certain ratio as culture media and the pure strain Penicillium rubens as zymocyte, and then fermenting under a certain temperature. The Mirabilitum Praeparatum prepared by present method is different from that of prepared by traditional technology significantly, and the present invention possesses more advantages than the traditional method. The Mirabilitum Praeparatum prepared by present method, its extract shows powerful antibacterial and anti-inflammatory activities, which can be prepared into pharmaceutical preparations to treat infectious diseases of mucous membrane and skin, such as cavum oris ulcer, paradentosis, glossitis, rhinitis, laryngopharyngitis, dermatitis, otitis media, uterine cervicitis, kysthitis, and other health products and cosmetics.

Claims

1. A method for the preparation of Mirabilitum Praeparatum by pure strain fermentation, characterized in that the culture media contains the ripe fruit (watermelon) of Citrullus lanatus (Thumb.) Matsumu.et Nakai and mirabilite (Na.sub.2SO.sub.4.10H.sub.2O), mixed according to a certain ratio (m/m), and the Penicillium rubens as zymophyte for fermenting at a certain condition to obtain the Mirabilitum Praeparatum.

2. A method for the preparation of Mirabilitum Praeparatum by pure strain fermentation characterized in that the zymophyte is Penicillium rubens.

3. A method for the preparation of Mirabilitum Praeparatum by pure strain fermentation characterized in the following steps: the fresh ripe fruit (watermelon) of Citrullus lanatus (Thumb.) Matsumu.et Nakai is cut into small pieces and put into fermenter, and then adds mirabilite according to the ratio of 100:50-100:1 (watermelon/mirabilite, m/m) and mix homogeneous. The mixture is sterilized with high-pressure (15 psi) steam for 20 min at 121° C., and inoculated the strain of Penicillium rubens to ferment for 15-35 d at 19-27° C., dissolving oxygen during fermentation. After that, the mixture is centrifugated for 10-20 min at the speed of 4000 r/min and the obtained supernate is dried with freezer dryer (−40° C., <13 Pa) to obtain the Mirabilitum Praeparatum.

4. The method described in claim 3 characterized in that the ratio of the ripe fruit (watermelon) of Citrullus lanatus (Thumb.) Matsumu.et Nakai and mirabilite (m/m) is 100:50-100:1, and the optimized ratio is 20:3.

5. The method described in claim 3 characterized in that the fermental temperature is 19-27° C., and the optimized temperature is 25° C.

6. The method described in claim 3 characterized in that the fermental period is 15-35 d, at least 15 d.

7. The applications of Mirabilitum Praeparatum (prepared with the methods in claims 1-6) in preparing pharmaceutical preparations, health care products and cosmetics to treat infectious diseases of mucous membrane and skin.

8. The applications described in claim 7 characterized in that Mirabilitum Praeparatum was lixiviated 2-4 times with 8-12 times (v/m) 95% ethanol, stirring thoroughly, the unsalable Na.sub.2SO.sub.4 was removed by filtering and the filtrate was retrieved ethanol under reduce pressure at 40-50° C. to obtain the Mirabilitum Praeparatum extract. The extract was added acceptable excipients of pharmaceutical preparations, health care products and cosmetics to prepare into any suitable products.

9. The applications described in claim 7 characterized in that the infectious diseases include cavum oris ulcer, paradentosis, glossitis, rhinitis, laryngopharyngitis, dermatitis, otitis media, uterine cervicitis, and kysthitis, respectively.

10. The applications described in claim 7 characterized in that the pharmaceutical preparations, health care products and cosmetics can be cavum oris gelata, pelliculae pro cavo oris, unguentum, tincture, aerosols, dry powder inhalation and ear drops.

Description

DESCRIPTION OF THE DRAWINGS

[0018] FIG. 1 is the fermental srain colonial morphology of Mirabilitum Praeparatum and the microscopic identification of the strain.

[0019] FIG. 2 is molecular biological assay of the Mirabilitum Praeparatum fermental srain, i.e., the results of rRNA gene sequences assy.

DETAILED DESCRIPTION

[0020] The technical solution of the present invention will be detailed introduced by the implementation method below. It should be pointed out that the following instructions just are some examples of protected technical solutions not the limitations to the technical solutions, and the protective range will take the CLAIMS of the present invention as valid.

EXAMPLE 1

The Separation and Purification of Mirabilitum Praeparatum Fermental Srain (Penicillium rubens)

[0021] 1. The fresh ripe fruit (watermelon) of Citrullus lanatus (Thumb.) Matsumu.et Nakai was cut into small pieces and put into fermenter, and then added 15% mirabilite (mirabilite/watermelon, m/m) to mix homogeneously. The mixture was fermented at room temperature for 15 d, and then took 10 mL fermentation broth into 250 mL conical flask with 90 mL sterile water and small glass beads. After that, the solution was oscillated on swing bed for 20 min to scatter the microorganic cells, standing for 20 s-30 s and the 10:1 dilution was obtained. The dilution was further diluted into the concentration of 10.sup.−2-10.sup.−9 successively for standby. The spread plate method was used to separate the strains and 0.2 mL of each solution was spread on plates with cultures of PDA, CZA, Sabourand and beef-protein medium respectively. The plates with PDA, CZA, Sabourand were cultured in incubator at 25° C., while the plate with beef-protein medium was cultured in incubator at 37° C. Take single colonies from plates for pure strain culture.

[0022] 2. Take the inner and outer surface fermentation broth with Inoculation loops spread on plates with cultures of PDA, CZA, Sabourand and beef-protein medium respectively (once a day). The plates with PDA, CZA, Sabourand were cultured in incubator at 25° C., while the plate with beef-protein medium was cultured in incubator at 37° C. Take single colonies from plates for pure strain culture.

[0023] 3. Observed the plate medium every day for monitoring the mycelium grown or single colonies forming, and picking the promycelium or single colonies to inoculate on sterile plate mediums as soon as possible. When the fungus colonies appeared, the single colonies were separated and inoculated on sterile plate mediums for purification according to the differences of colonial morphology, colonial colour, and the time of outgrow. The purified strain was inoculate on PDA or beef-protein slant culture-medium and numbered to storage in refrigerator at 4° C.

[0024] 4. The results: a fungus was separated from the fermentation broth of Mirabilitum Praeparatum, and identified as Penicillium by its morphology.

[0025] 5. Thes colonial morphology, microscopic, and Molecular Biology identifications of Mirabilitum Praeparatum fermental strain.

[0026] Morphology and microscopic identifications: the strain grew slow in Malt Extract Agar (MEA), cultured away from light for 5 d at 25° C. and the diameter of the colony was up to 15-17 mm, velvet in texture, producing much conidial fructification, conidial powder was pewter, the back of the colony was sandy beige, no hydrophilic pigment, the conidiophore was not specialization obviously, 3.0-5.0 μm in breadth, cytoderm was smoothly, 2-4 whorl penicillus and surface loosening, the phialide was 7.4-13.9'2.6˜3.4 μm, conidiospore was subsphaeroidal and broad ellipse, reseda, smooth surface, 3.0-5.0×2.5-4.0 μm, and there was no sexual spore. (See the FIG. 1).

[0027] The identification of the strain was commissioned to Institute of Microbiology, Chinese Academy of Sciences and the report [(2016) Micro discrimination, 032] was issued. The genes of the strain contains the 18S rRNA fragment, ITS1, 5.8S rRNA, ITS2, and 28S rRNA fragment sequences. Therefore, the strain was identified as Penicillium rubens (See the FIG. 2).

EXAMPLE 2

Pure Strain Fermentation Prepared Mirabilitum Praeparatum in Various Proportions of Fermental Materials

[0028] The fresh ripe fruit (watermelon) of Citrullus lanatus (Thumb.) Matsumu.et Nakai is cut into small pieces and put into fermenter, and then adds mirabilite according the ratio of 2:1, 10:3, 5:1, 20:3, 10:1, and 20:1 respectively (watermelon/mirabilite, m/m) to mix homogeneously. The mixture is sterilized with high-pressure (15 psi) steam for 20 min at 121° C., and inoculate pure strain of Penicillium rubens to ferment for 15 d at 25° C., dissolving oxygen during fermentation. After that, the mixture is centrifugated for 10-20 min at the speed of 4000 r/m in and the obtained supernate is dried with freezer dryer (−40° C., <13 Pa) to obtain the Mirabilitum Praeparatum.

TABLE-US-00001 TABLE 1 The antibacterial activities (minimum inhibitory concentration, MIC) of pure strain fermentation prepared Mirabilitum Praeparatum in various proportions of fermental materials (watermelon/mirabilite, m/m) (MIC, mg/mL) Strains 2:1 10:3 5:1 20:3 10:1 20:1 Aeruginosus bacillus — 12.53 3.13 3.13 6.26 25.06 Escherichia coli — 6.26 3.13 3.13 3.13 25.06 Staplylococcus albus — 12.53 3.13 3.13 3.13 25.06 Staphylococcus citreus — 12.53 3.13 3.13 3.13 25.06 Shigella flexneri — 12.53 3.13 3.13 6.26 25.06 Staphylococcus aureus — 12.53 6.26 3.13 6.26 25.06 Bacillus paratyphosus B — 12.53 3.13 3.13 6.26 25.06 Beta-hemolytic streptococci — 12.53 3.13 3.13 6.26 25.06

EXAMPLE 3

Pure Strain Fermentation Prepared Mirabilitum Praeparatum in Various Temperatures

[0029] The fresh ripe fruit (watermelon) of Citrullus lanatus (Thumb.) Matsumu.et Nakai is cut into small pieces and put into fermenter, and then adds mirabilite according the ratio of 20:3 (watermelon/mirabilite, m/m) to mix homogeneously. The mixture is sterilized with high-pressure (15 psi) steam for 20 min at 121° C., and inoculate pure strain of Penicillium rubens to ferment for 15 d at 21° C., 23° C., 25° C., 27° C., and 31° C. respectively, dissolving oxygen during fermentation. After that, the mixture is centrifugated for 10-20 min at the speed of 4000 r/min and the obtained supernate is dried with freezer dryer (−40° C., <13 Pa) to obtain the Mirabilitum Praeparatum.

TABLE-US-00002 TABLE 2 The antibacterial activities of pure strain fermentation prepared Mirabilitum Praeparatum in various temperatures (MIC, mg/mL) 19° 22° 25° 28° 31° 33° Strains C. C. C. C. C. C. Aeruginosus bacillus 6.26 6.26 3.13 12.53 50.12 50.12 Escherichia coli 6.26 6.26 3.13 12.53 50.12 50.12 Staplylococcus albus 6.26 6.26 3.13 12.53 50.12 50.12 Staphylococcus citreus 6.26 6.26 3.13 12.53 50.12 50.12 Shigella flexneri 6.26 6.26 3.13 12.53 50.12 50.12 Staphylococcus aureus 6.26 6.26 3.13 12.53 50.12 50.12 Bacillus paratyphosus B 6.26 6.26 3.13 12.53 50.12 50.12 Beta-hemolytic 6.26 6.26 3.13 12.53 50.12 50.12 streptococci

EXAMPLE 4

Pure Strain Fermentation Prepared Mirabilitum Praeparatum in Various Fermental Times

[0030] The fresh ripe fruit (watermelon) of Citrullus lanatus (Thumb.) Matsumu.et Nakai is cut into small pieces and put into fermenter, and then adds mirabilite according the ratio of 20:3 (watermelon/mirabilite, m/m) to mix homogeneously. The mixture is sterilized with high-pressure (15 psi) steam for 20 min at 121° C., and inoculate pure strain of Penicillium rubens to ferment for 3 d, 7 d, 10 d, 15 d, 20 d, 25 d, and 30 d respectively at 25° C., dissolving oxygen during fermentation. After that, the mixture is centrifugated for 10-20 min at the speed of 4000 r/m in and the obtained supernate is dried with freezer dryer (−40° C., <13 Pa) to obtain the Mirabilitum Praeparatum.

TABLE-US-00003 TABLE 3 The antibacterial activities of pure strain fermentation prepared Mirabilitum Praeparatum in various fermental periods (MIC, mg/mL) Strains 3 d 7 d 10 d 15 d 20 d 25 d 30 d Aeruginosus bacillus 50.12 12.53 6.26 3.13 3.13 3.13 12.53 Escherichia coli 50.12 12.53 6.26 3.13 3.13 3.13 12.53 Staplylococcus albus 50.12 12.53 6.26 3.13 3.13 3.13 12.53 Staphylococcus citreus 50.12 12.53 6.26 3.13 3.13 3.13 12.53 Shigella flexneri 50.12 12.53 6.26 3.13 3.13 3.13 12.53 Staphylococcus aureus 50.12 12.53 6.26 3.13 3.13 3.13 12.53 Bacillus 50.12 12.53 6.26 3.13 3.13 3.13 12.53 paratyphosus B Beta-hemolytic 50.12 12.53 6.26 3.13 3.13 3.13 12.53 streptococci

EXAMPLE 5

Determination of the Optimized Preparation Technology of Mirabilitum Praeparatum

[0031] The Examples 2-4 about Mirabilitum Praeparatum showed that the optimized ratio of the ripe fruit (watermelon) of Citrullus lanatus (Thumb.) Matsumu.et Nakai and mirabilite was 20:3 (m/m), the optimized fermental temperature was 25° C., and the optimized fermental time was 15-17 d. As a result, the optimized preparation technology of Mirabilitum Praeparatum was determined as following: The fresh watermelon is cut into small pieces and put into fermenter, and then adds mirabilite according the ratio of 20:3 (watermelon/mirabilite, m/m) to mix homogeneously. The mixture is sterilized with high-pressure (15 psi) steam for 20 min at 121° C., and inoculate pure strain of Penicillium rubens to ferment for at least 15 d at 25° C., dissolving oxygen during fermentation. After that, the mixture is centrifugated for 10-20 min at the speed of 4000 r/min and the obtained supernate is dried with freezer dryer (−40° C., <13 Pa) to obtain the Mirabilitum Praeparatum.

EXAMPLE 6

The Antibacterial Test of Mirabilitum Praeparatum in Vitro

[0032] The Mirabilitum Praeparatum prepared in Example 5 was lixiviated 3 times with 95% ethanol of 8 times amount (v/m) at 20° C. The extracted liquid was retrieved ethanol under reduce pressure after filtered the undissolved Na.sub.2SO.sub.4 to obtained Mirabilitum Praeparatum extract. The antibacterial test in vitro was used to investigate the activities of. The selected bacterial strains are common pathogenic bacteria of cavum oris, respiratory tract and digestive tract, such as Aeruginosus bacillus, Staphylococcus aureus, Staphylococcus citreus, Staplylococcus albus, Aeruginosus bacillus, Bacillus paratyphosus B, Beta-hemolytic streptococci, Shigella flexneri, and Escherichia coli.

[0033] Determination of MICs: On a 96-well microplate, the first one in each row (12 wells) was added 100 μL broth culture with Mirabilitum Praeparatum extract, while the remaining 11 wells were added with 100 μL broth culture for serial dilution. Another 100 μL each solution was added into the second well and then 100 μL was sequentially transferred to the next wells till the tenth well. The last two wells served as growth control and sterility check. And then 100 μL of inoculum was added into all the wells except the last one in which 100 μL broth instead. The microplate was incubated at 37° C. for 18 h and a microplate reader was used to monitor the growth of the bacterial strains. The parallel experiment was tested for 3 times and the result was showed in table 4.

TABLE-US-00004 TABLE 4 The antibacterial activities of pure strain fermentation prepared Mirabilitum Praeparatum extract Strains (MIC, mg/mL) Aeruginosus bacillus 3.13 Escherichia coli 3.13 Staplylococcus albus 3.13 Staphylococcus citreus 3.13 Shigella flexneri 3.13 Staphylococcus aureus 3.13 Bacillus paratyphosus B 3.13 Beta-hemolytic streptococci 3.13

EXAMPLE 7

Mirabilitum Praeparatum Cavum Oris Gelata

[0034] Carbomer gelatin matrix was weighted and put into mortar, added glycerol and grinded to moist. After that, the mixture was added triethanolamine and grinded into transparent gelatin matrix. An appropriate amount of Mirabilitum Praeparatum extract and ethylparaben was weighted added purified water and heated to dissolve. The solution was mix with the transparent gelatin matrix before it become cooler, and grinded homogeneous thoroughly to obtain Mirabilitum Praeparatum cavum oris gelata after cooled.

EXAMPLE 8

Mirabilitum Praeparatum Pelliculae Pro Cavo Oris

[0035] The polyvinyl alcohol and carboxymethylcellulose sodium was soaked with an appropriate amount of purified water for inflation and heated on water bath to dissolve, respectively. The both were mixed homogeneous for standby. An appropriate amount of Mirabilitum Praeparatum extract was dissolved with some hot purified water, added saccharin sodium and glycerol and stirred to dissolve. The solution was mixed with the standby polyvinyl alcohol and carboxymethylcellulose sodium mixture, added an appropriate amount of purified water to required amount and mix homogeneous, and then stranded for depleting the bubble to paint film. The film was dried, defilming and cut into required size. The film was exposure to ultraviolet lamp for sterilization and then tight packed to obtain the Mirabilitum Praeparatum pelliculae pro cavo oris.

EXAMPLE 9

Mirabilitum Praeparatum Buccal Tablets

[0036] 65 g Mirabilitum Praeparatum extract was mixed with 70 g glucose, 75 g sucrose, and 75 g starch homogeneously and granulated with 95% ethanol, dried and tableting to obtain Mirabilitum Praeparatum buccal tablets.

EXAMPLE 10

Mirabilitum Praeparatum Toothpaste Cosmetics

[0037] 5 g Mirabilitum Praeparatum extract was mixed with weighted silicic acid hydrate, glycerol, sodium lauryl sulfonate, carboxymethylcellulose sodium, spice, and sweetening agent homogeneously and put into paste making machine for grinding thoroughly to obtain 100 g toothpaste. The toothpaste was used for preventing and nursing cavum oris ulcer, paradentosis, and gingivitis.

EXAMPLE 11

The Clinical Observation of Mirabilitum Praeparatum Cavum Oris Gelata—Treatment on Cavum Oris Ulcer

[0038] Drug: Mirabilitum Praeparatum cavum oris gelata

[0039] Patients: 50 outpatients, including 28 cases of man and 22 cases of women, aged from 18 to 62. The patients with endogenous diseases were excluded.

[0040] Medication: An appropriate amount of Mirabilitum Praeparatum cavum oris gelata was spread on par aff., 4-6 times a day for 5 d.

[0041] Criteria of evaluating curative effects: 1) Excellence: pain disappeared, the cavum oris ulcer healed. 2) Effective: pain alleviated, the cavum oris ulcer area decreased, swollen reduced, and unhealed. 3) Ineffective: pain unalleviated or aggravated, and cavum oris ulcer unimproved.

[0042] The result: the total effective rate was 94.2%, no adverse reaction.

[0043] The cavum oris ulcer, belongs to “kou Chuang” in Chinese medical, which caused by surfeit pungent, accumulation of heart and spleen, and catching pathogens of wind, heating, and dryness. The Mirabilitum Praeparatum possesses the potencies of clearing away heat and reducing fire and reduces swelling and alleviates pain. The effect of Mirabilitum Praeparatum on cavum oris ulcer was significantly but no adverse reaction, and convenient in medication.

EXAMPLE 12

The Clinical Observation of Mirabilitum Praeparatum Cavum Oris Gelata—Treatment on Acute and Chronic Pharyngolaryngitis

[0044] Drug: Mirabilitum Praeparatum cavum extract.

[0045] Patients: 43 outpatients, including 23 cases of man and 20 cases of women, aged from 18 to 57. The patients with endogenous diseases were excluded.

[0046] Medication: An appropriate amount of Mirabilitum Praeparatum extract was administered under tongue, 2˜5 times a day for 7 d.

[0047] Criteria of evaluating curative effects: 1) Clinical cured: all symptoms of sore throat and cough disappeared after administrated for less than 7d. 2) Excellence: most symptoms of sore throat and cough disappeared after administrated for less than 7d. 3) Effective: symptoms of sore throat and cough reduced for more than 50% after administrated for less than 7 d. Ineffective: symptoms of sore throat and cough reduced for less than 50% or aggravated after administrated for less than 7 d.

[0048] The result: the total effective rate was 92.25%, no adverse reaction.

EXAMPLE 13

The Clinical Observation of Mirabilitum Praeparatum Cavum Oris Gelata—Treatment on Tonsillitis

[0049] Drug: Mirabilitum Praeparatum buccal tablets.

[0050] Patients: 60 outpatients, including 28 cases of man and 32 cases of women, aged from 18 to 57. The patients with endogenous diseases were excluded.

[0051] Medication: Mirabilitum Praeparatum buccal tablets, 3-5 tablets a day for 7 d.

[0052] Criteria of evaluating curative effects (bacteriology criteria): 1) Clearance: all pathogenic bacteria disappeared and no other pathogenic bacteria appeared after administrated for 7 d. 2) Unclearance: the pathogenic bacteria unchanged after administrated for 7 d. 3) Bacterial replacement: all pathogenic bacteria were cleared and other pathogenic bacteria appeared but no infection after administrated for 7 d, and not need to be treated.

[0053] The result: the bacterial clearance was up to 87.8% and the total effective rate was 92.25%, no adverse reaction.

[0054] The Examples described above were the optimizations of the present invention. It should be pointed out that the invention could be improved and polished on the basis of the present materials by common technicians of this field, but the improvements and polishes of the present invention should also be contained in protection domain.